Literature DB >> 6497657

Cross-reactivity between cowpox and vaccinia viruses with monoclonal antibodies. Brief report.

N Kitamoto, E Goto, S Tanimoto, T Tanaka, H Miyamoto, N Wakamiya, K Ikuta, S Ueda, S Kato.   

Abstract

Hybridoma cell lines producing monoclonal antibodies against cowpox virus (CPV) and vaccinia virus (VV) were established to examine the specific and cross-reactive antigenic determinants of these viruses. Monoclonal antibodies against CPV (LB red strain) and VV (Lister strain and Ikeda strain) were classified into several groups on the basis of the results of immunofluorescence and haemagglutination inhibition tests. It was suggested that the groups defined above include the group of antibodies reacting with each of known major antigens of poxvirus, i.e. nucleoprotein (NP) antigen, heat labile and stable complex (LS) antigen, haemagglutinin (HA), cell surface antigen (CSA) and type A inclusion body (A).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497657     DOI: 10.1007/bf01309377

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Serological relationships within the poxvirus group: an antigen common to all members of the group.

Authors:  G M WOODROOFE; F FENNER
Journal:  Virology       Date:  1962-03       Impact factor: 3.616

2.  Pox viruses.

Authors:  A W DOWNIE; K R DUMBELL
Journal:  Annu Rev Microbiol       Date:  1956       Impact factor: 15.500

3.  Immune hemadsorption by cells infected with poxviruses.

Authors:  H Miyamoto; S Kato
Journal:  Biken J       Date:  1968-12

4.  Biogenesis of poxviruses: genetically controlled modifications of structural and functional components of the plasma membrane.

Authors:  S Weintraub; S Dales
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

5.  Vaccinia-specific hemagglutinin.

Authors:  Y Ichihashi
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

6.  Two components specifically responsible for hemagglutination in vaccinia and cowpox viruses.

Authors:  K Ikuta; H Miyamoto; S Kato
Journal:  Virology       Date:  1979-07-15       Impact factor: 3.616

7.  Monoclonal antibodies specific to and cross-reactive with Marek's disease virus and herpesvirus of turkeys.

Authors:  K Ikuta; H Honma; K Maotani; S Ueda; S Kato; K Hirai
Journal:  Biken J       Date:  1982-12

8.  Studies on the early antigens induced by vaccinia virus.

Authors:  Y Ueda; I Tagaya; H Amano; M Ito
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

9.  Comparative studies on LS antigens induced by vaccinia and cowpox viruses.

Authors:  K Ikuta; H Miyamoto; S Kato
Journal:  J Gen Virol       Date:  1979-12       Impact factor: 3.891

10.  Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.

Authors:  Y Ueda; I Tagaya
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  6 in total

1.  Partial antigenic characterization of buffalopox virus.

Authors:  P Anand Kumar; G Butchaiah
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

2.  Serum antibody against Helicobacter pylori assayed by a new capture ELISA.

Authors:  H Nakata; H Itoh; Y Yokoya; J Kawai; S Nishioka; K Miyamoto; N Kitamoto; H Miyamoto; T Tanaka
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

3.  Polypeptide analysis with monoclonal antibodies of A type inclusion bodies induced by cowpox virus.

Authors:  N Kitamoto; S Tanimoto; K Hiroi; T Tanaka; H Miyamoto; N Wakamiya; K Ikuta; S Ueda; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Detection of immunoreactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease.

Authors:  H Miyamoto; T Tanaka; N Kitamoto; Y Fukuda; T Shimoyama
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

5.  Cross-reactivity among cowpox, ectromelia and vaccinia viruses with monoclonal antibodies recognizing distinct antigenic determinants in A-type inclusion bodies.

Authors:  N Kitamoto; S Tanimoto; K Hiroi; H Miyamoto; N Wakamiya; S Ueda; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Genomic expression libraries for the identification of cross-reactive orthopoxvirus antigens.

Authors:  Lilija Miller; Marco Richter; Christoph Hapke; Daniel Stern; Andreas Nitsche
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.